Jianpi-Huayu Formula Inhibits Development of Hepatocellular Carcinoma by Regulating Expression of miR-602, Which Targets the Gene

The traditional Chinese medicine formula Jianpi-Huayu (JPHY) has been reported to be effective in the treatment of hepatocellular carcinoma (HCC). However, its underlying mechanism remains unclear. In this article, we employed an orthotopic transplantation model in nude mice to explore whether JPHY...

Descripció completa

Dades bibliogràfiques

Autors principals:	Yajing Huang MD, Cheng Zhou MD, Huihong Wen MD, Yongxu Chen MD, Yingjie Xie MD, Xiaohe Lan MD, Juze Lin MD, PhD, Xuhui Huang MD, Yousheng Mo MD, PhD, Cong Yang MD, PhD, Qi Wang MD, PhD, Changjun Wang MD, PhD
Format:	Artigo
Idioma:	Inglês
Publicat:	SAGE Publishing 2020-02-01
Col·lecció:	Integrative Cancer Therapies
Accés en línia:	https://doi.org/10.1177/1534735419900804
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!